Delivery Order SPE2DB20D3103-SPE2DB23FP9E4
- Not listed
- This federal contract award, valued at $20,359.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period ending on January 31, 2024. The contract is a Firm Fixed Price (FFP) vehicle with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, plays a critical...
- This federal contract award, with a value of $56,094.82, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the DLA. This appears to be a firm-fixed price delivery order contract, with a completion date of February 6, 2024. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen...
- This federal contract award, valued at $25,171.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This is an open competition contract with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award, valued at $8,193.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S, with a completion date of January 4, 2024. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, valued at $10,678.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order contract is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract is a firm fixed-price delivery order with an ultimate completion date of December 3, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $76,757.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with an ultimate completion date of September 2, 2022. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $21,801.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of May 10, 2024. The contract is a Delivery Order and has a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $40,534.82, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp, the prime contractor, is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award, valued at $16,913.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. The contract covers the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military and veteran healthcare programs. This award was made...
- This federal contract award, valued at $20,373.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through May 1, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP9E4Delivery Order
This federal contract award, valued at $43,655.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of September 28, 2023. The contract is a Firm Fixed Price (FFP) arrangement and was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, to deliver a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.7k | 9/27/23 |